Valuation: Sudarshan Pharma Industries Limited

Market Cap 9.57B 100M 90.16M 83.36M 75.49M 141M 143M 997M 397M 5.01B 377M 369M 15.9B P/E 2025
46.3x
P/E 2026 25x
Enterprise Value 12.41B 130M 117M 108M 97.89M 183M 185M 1.29B 515M 6.49B 489M 479M 20.62B EV / Sales 2025
1.79x
EV / Sales 2026 1.23x
Free-Float
22.19%
Yield 2025 *
-
Yield 2026 -
10-06 Sudarshan Pharma Industries Limited, along with its promoters Hemal Mehta and Sachin Mehta, cancelled the agreement to acquire a 12.5% stake in Medtherapy Biotechnology Inc. CI
09-27 Amit Jatin Mehta acquired 51% stake in Ishwari Healthcare Pvt Ltd from Sudarshan Pharma Industries Limited for INR 14 million. CI
09-04 Sudarshan Pharma Industries Limited, Hemal Mehta and Sachin Mehta, agreed to acquire 12.5% stake in Medtherapy Biotechnology Inc. CI
08-12 Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-10 Sudarshan Pharma Industries Limited Incorporates Wholly-Owned Subsidiary In United States Of America CI
05-12 Sudarshan Pharma Industries Ltd to consider issuance of foreign currency convertible bonds RE
05-04 Sudarshan Pharma Industries CFO Resigns; Shares up 3% MT
04-30 Sudarshan Pharma Industries Limited Announces Resignation of Sachin Mehta as Chief Financial Officer, Effective May 1, 2026 CI
04-30 Sudarshan Pharma Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-28 4,813,182 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2026. CI
02-26 Sudarshan Pharma Industries says GST inspection conducted by Mumbai Tax Department RE
01-28 Sudarshan Pharma Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
12-30 Sudarshan Pharma Industries Limited completed the acquisition of Ratna Lifesciences Pvt Ltd. CI
1 day+7.83%
1 week+7.46%
Current month+0.83%
1 month-2.31%
3 months-9.22%
6 months+24.33%
Current year+36.52%
1 week 29.01
Extreme 29.01
38
1 month 29.01
Extreme 29.01
39
Current year 18.5
Extreme 18.5
42.79
1 year 18.5
Extreme 18.5
42.79
3 years 5.82
Extreme 5.82
53.5
5 years 5.18
Extreme 5.185
53.5
10 years 5.18
Extreme 5.185
53.5
Manager TitleAgeSince
Chief Executive Officer 41 2018-11-07
Chief Executive Officer 48 2018-11-07
Chief Operating Officer - 2025-10-31
Director TitleAgeSince
Chairman 48 2018-11-07
Director/Board Member 41 2025-08-13
Director/Board Member 32 2023-07-20
Change 5-day change 1-year change 3-year change Capi.($)
+7.83%+7.46%+62.74%+363.29% 93.45M
+0.37%+1.48%+57.24%+127.95% 1,143B
+0.97%+5.22%+45.10%+84.48% 647B
+0.35%+1.03%+26.46%+102.79% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-1.06%-6.30%+61.37%+36.77% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.60%+2.72%+54.15%+71.08% 242B
+0.13%+3.81%+35.24%+104.99% 197B
Average +0.95%+0.73%+42.86%+103.42% 402.76B
Weighted average by Cap. +0.30%+0.71%+44.58%+87.11%

Financials

2025 2026
Net sales 5.05B 53.03M 47.58M 43.99M 39.84M 74.43M 75.33M 526M 209M 2.64B 199M 195M 8.39B 7.03B 73.82M 66.23M 61.23M 55.46M 104M 105M 732M 292M 3.68B 277M 271M 11.68B
Net income 160M 1.68M 1.5M 1.39M 1.26M 2.35M 2.38M 16.61M 6.62M 83.49M 6.29M 6.15M 265M 233M 2.45M 2.2M 2.03M 1.84M 3.43M 3.48M 24.27M 9.67M 122M 9.18M 8.99M 387M
Net Debt 1.69B 17.71M 15.89M 14.69M 13.31M 24.86M 25.16M 176M 69.96M 883M 66.46M 65.06M 2.8B 2.84B 29.81M 26.74M 24.73M 22.39M 41.84M 42.34M 296M 118M 1.49B 112M 110M 4.72B
Projected Income Statement - Annual - Sudarshan Pharma Industries Limited
Logo Sudarshan Pharma Industries Limited
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.
Employees
64
Date Price Change Volume
26-10-28 ₹37.61 +7.83% 81,880
26-10-27 ₹34.88 +9.03% 51,590
26-10-26 ₹31.99 +2.37% 240,000
26-10-23 ₹31.25 -4.05% 40,000
26-10-22 ₹32.57 -3.64% 52,000
  1. Stock Market
  2. Stocks
  3. SUDARSHAN Stock